Sarepta

Duchenne muscular dystrophy genetic test DMD
Biotech

Young participant in Pfizer's DMD gene therapy trial dies

A young boy with DMD participating in Pfizer’s phase 2 gene therapy trial has died, the pharma shared in a May 7 letter.
Gabrielle Masson May 7, 2024 4:29pm
pumpkin pedestal Halloween

Pfizer’s DMD gene therapy now ‘main game in town,' CSO says

Oct 31, 2023 2:28pm
Publicly traded hotel companies beholden to Wall Street

Sarepta rewarded by Wall Street for FDA committee shocker

May 15, 2023 11:05am
duchenne muscular dystrophy

FDA skips AdComm for Sarepta's DMD therapy, sets decision date

Feb 28, 2023 8:00pm
no money broken bank poor bankruptcy

Lysogene looks for saving grace after trial flop

Dec 7, 2022 11:15am
Nasdaq

With Sarepta in its sights, PepGen prices IPO to fund DMD trials

May 6, 2022 8:50am